The Winners And Losers In The CRISPR Patent Fight

Published: Feb 16, 2017

s you’ve likely heard if you work in the biosciences, the Broad Institute of Harvard and MIT just won a big patent battle over the revolutionary gene editing technology known as CRISPR-Cas9. The ruling awards patents for using the technique in mammalian cells — including to develop new therapies for disease —to the Broad and its acclaimed researcher Feng Zhang.

Back to news